Cognoptix Company
Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available test, enabling early diagnosis and treatment.
The company was founded in 2001 and headquartered in Marlborough, Massachusetts.
Founded Date:
2001-01-01
Last Funding Date:
2020-09-28
Headquarters:
Marlborough,Massachusetts,United States,North America
Total Funding:
46349000
Funding Status:
private
Industry:
Electrometry
Super Industry:
Quantum Sensing
Funding Total Value:
46349000
Last Funding Total Usd:
2600000
Last Funding Total Currency:
USD
Last Funding Total Value:
2600000
Founders:
Lee Goldstein,Leo Chylack
Phone Number:
508-251-1546